Robert Emanuele
Direttore/Membro del Consiglio presso ARTELO BIOSCIENCES, INC.
Patrimonio netto: 1 118 $ in data 30/04/2024
Posizioni attive di Robert Emanuele
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARTELO BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 20/09/2017 | - |
Independent Dir/Board Member | 20/09/2017 | - | |
Liferaft Biosciences, Inc. , | Amministratore Delegato | - | - |
Presidente | - | - | |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | 05/06/2023 | - | |
Fondatore | - | - | |
Amministratore Delegato | 01/05/2018 | 05/06/2023 | |
Direttore operativo | - | - |
Storia della carriera di Robert Emanuele
Precedenti posizioni note di Robert Emanuele
Società | Posizione | Inizio | Fine |
---|---|---|---|
SAVARA INC. | Corporate Officer/Principal | - | 28/10/2016 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 05/05/2011 | 01/10/2016 |
DAVITA INC. | Corporate Officer/Principal | 01/04/2011 | 01/04/2011 |
Synthrx, Inc.
Synthrx, Inc. Miscellaneous Commercial ServicesCommercial Services Synthrx, Inc. develops a purified form of a rheologic and antithrombotic agent solution. The company is headquartered in Bellaire, TX. | Amministratore Delegato | 01/06/2008 | 01/04/2010 |
Presidente | 01/06/2008 | 01/04/2010 | |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA. | Corporate Officer/Principal | 01/11/2006 | 01/05/2008 |
AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/08/2002 | 01/01/2006 |
░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░ ░ ░░ ░░░░ ░░ ░░░░░░░ ░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Robert Emanuele
Colorado State University | Undergraduate Degree |
The University of Colorado | Masters Business Admin |
Stritch School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 17 |
Posizioni
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 3 |
Settori
Health Technology | 9 |
Consumer Services | 4 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
LADRX CORPORATION | Health Technology |
DAVITA INC. | Health Services |
ARTELO BIOSCIENCES, INC. | Health Technology |
SAVARA INC. | Health Technology |
Aziende private | 9 |
---|---|
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Kémia, Inc.
Kémia, Inc. Pharmaceuticals: MajorHealth Technology Kémia, Inc. discovered and developed novel small molecule therapeutics for inflammation, cancer, HIV, diabetes and bone diseases. The firm specialized in the fields of medicinal and analytical chemistry, biology, pharmacology, pharmacokinetics, pharmacodynamics, and clinical development. The company was founded in 2002 and was headquartered in San Diego, CA. | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Dupont Critical Care, Inc. | |
Synthrx, Inc.
Synthrx, Inc. Miscellaneous Commercial ServicesCommercial Services Synthrx, Inc. develops a purified form of a rheologic and antithrombotic agent solution. The company is headquartered in Bellaire, TX. | Commercial Services |
Liferaft Biosciences, Inc. , | Miscellaneous |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Robert Emanuele
- Esperienza